Simon MacKenzie

Chief Executive Officer | Leading tissue therapeutics programs

Berlin, Berlin, Germany

About

My expertise and experience lie in building biotech and med-tech organizations in Europe, US and Asia, delivering discovery, therapeutics and technology programs, developing and launching new technologies, driving strategic and operational focus, investor funding and acquisition structuring, alliance management and business partnerships and collaborations. With over 25 years of C-suite, senior business, scientific and operational roles, I bring strong scientific and business leadership, delivering value for life science organizations. My passion focuses on supporting dynamic innovation, entrepreneurship and partnerships in life science, most recently in the regenerative, personalized medicine, and discovery space. I thrive on driving innovation and building high-performing teams to address complex challenges, providing coaching and mentoring combined with considered strategic problem solving to achieve goals.

Experience

  • Cellbricks Therapeutics (2 yrs 7 mos)
    • Chief Executive Officer
      Dec 2024 - Present · 1 yr 7 mos

      Building a regenerative medicine biotech from an academic spinout and leading the tissue therapeutics programs towards the clinic. Assembled and mentoring a multidisciplinary team specializing in cell and tissue engineering, 3D bioprinting, biomaterial science and engineering. Fostering partnerships in technology, clinical development, and regulatory affairs to advance the therapeutic programs towards the clinic. Supporting investment and developing pharma partnerships.

    • Chief Operations Officer
      Dec 2023 - Dec 2024 · 1 yr 1 mo

  • Mentor at Future Worlds
    Nov 2017 - Present · 8 yrs 8 mos

    Part of the mentor community at Future Worlds, working with start-ups and aspiring entrepreneurs at the University of Southampton.

  • Chairman at Cytochroma
    Feb 2023 - Jul 2023 · 6 mos

    Founder support, investment and business model development for an iPSC derived cell model company.

  • Chief Executive Officer at REGENHU US INC
    Apr 2020 - Jul 2022 · 2 yrs 4 mos

    Launched the North American center for 3D Bioprinting alliance management, scientific and technical support.

  • Chief Executive Officer at REGENHU
    Nov 2019 - Jul 2022 · 2 yrs 9 mos

    Transformed, grew and prepared for acquisition, a 3D bioprinting pioneer in drug discovery, regenerative medicine and personalized medicine technologies.